Susquehanna International Group’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Susquehanna International Group’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-159,374	Closed	-$6.33M	–	10608
2016 Q3	$6.33M	Buy	+159,374	New	+$1.78M	﹤0.01%	1975
2015 Q2	–	Sell	-3,438	Closed	-$50.3K	–	10725
2015 Q1	$38K	Buy	3,438 +1,924	+127%	+$20.7K	﹤0.01%	9200
2014 Q4	$12K	Buy	+1,514	New	+$13K	﹤0.01%	9510
2014 Q2	–	Sell	-14,018	Closed	-$1.58M	–	10347
2014 Q1	$1.58M	Buy	+14,018	New	+$984K	﹤0.01%	4715

Susquehanna International Group's TBRA Position: Q4 2016 in Review

Susquehanna International Group sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 159,374 shares — an estimated $6.33M sold.

Susquehanna International Group first reported a position in TBRA in Q1 2014 and held it in 4 quarters. The position peaked at $6.33M in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Susquehanna International Group reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Susquehanna International Group sold 159,374 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $6.33M.
Susquehanna International Group first reported a position in Tobira Therapeutics, Inc. Common Stock in Q1 2014 and held it in 4 quarters.
Susquehanna International Group's Tobira Therapeutics, Inc. Common Stock position peaked at $6.33M in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Susquehanna International Group's 13F filing for Q4 2016, filed 14 Feb 2017.